BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
EQH
Equitable Holdings, Inc.
EQH has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EQH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
EQH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQH.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over EQH in the historical PE scenario, which offers more potential upside but is not a forecast.
EQH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.3x | $22.16 | -60% |
| Forward | 6.5x | $55.63 | — |
| Fair | 9.7x | $50.28 | -9.6% |
| Current | 11x | $55.63 | — |
| Expensive | 17x | $87.41 | +57% |
Historical ranges are pointers, not guarantees.
EQH's PE is in its fair range at 11x. If earnings grow as analysts expect, today's price would be 6.5x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over EQH on the outlook, with more favorable revenue expectations.
EQH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect EQH's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over EQH on earnings, with more consistent year-over-year improvement.
EQH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.49 | +63% |
| Q3 2026 | $5.20 | +$8.00 |
| Q2 2026 | -$3.32 | -377% |
| Q1 2026 | -$2.85 | -178% |
| Q4 2025 | -$4.83 | -228% |
| Q3 2025 | -$2.80 | -$1.81 |
| Q2 2025 | $1.20 | -52% |
| Q1 2025 | $3.64 | +9.3% |
| Q4 2024 | $3.78 | +8.6% |
EQH has returned to profit: it earned $5.20 per share over the past year, after losing money the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over EQH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
EQH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.9B | +168% |
| Q2 2026 | $1.7B | -30% |
| Q1 2026 | $4.2B | -7.6% |
| Q4 2025 | $3.3B | -9.5% |
| Q3 2025 | $1.5B | -53% |
| Q2 2025 | $2.4B | -33% |
| Q1 2025 | $4.6B | +105% |
| Q4 2024 | $3.6B | +67% |
EQH's revenue is recovering but still below its 2020 peak: $3.9B last quarter, up 168% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +129 points |
| Q2 2026 | -30% | -14 points |
| Q1 2026 | 21% | +17 points |
| Q4 2025 | 11% | -23 points |
| Q3 2025 | -93% | -93 points |
| Q2 2025 | -15% | -35 points |
| Q1 2025 | 3.8% | -7.3 points |
| Q4 2024 | 33% | +71 points |
EQH has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
EQH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +342% |
| Q2 2026 | $643M | +89% |
| Q1 2026 | $499M | +216% |
| Q4 2025 | -$154M | -139% |
| Q3 2025 | $369M | -46% |
| Q2 2025 | $341M | -62% |
| Q1 2025 | $158M | +410% |
| Q4 2024 | $400M | +$792M |
EQH has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EQH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -4.9M shares |
| 1 year | -7.7% | -22.8M shares |
| 3 years | -21% | -74.6M shares |
| 5 years | -34% | -141M shares |
| Available history | -45% | -220M shares |
EQH has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $238M |
| Q2 2026 | $366M |
| Q1 2026 | $147M |
| Q4 2025 | $277M |
| Q3 2025 | $676M |
| Q2 2025 | $235M |
| Q1 2025 | $262M |
| Q4 2024 | $260M |
EQH spent $1B buying back its own shares over the past year, down 28% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EQH Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EQH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 74.5 | Neutral |
EQH's weekly RSI is 66 (neutral) and its Stochastic is 75 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
EQH PE vs Financial Services Sector
| Metric | EQH | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 18% below |
| PE % | 57 | 63 | 6 pts below |
EQH has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
EQH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $53.4 | 4.1% above |
| 20 week MA | $51.4 | 8.1% above |
| 50 week MA | $46.4 | 20% above |
| 100 week MA | $48.8 | 14% above |
| 200 week MA | $41.4 | 34% above |
EQH has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
EQH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $25.1 | +2% |
| 2021 | $25.1 | $33.0 | +31% |
| 2022 | $33.0 | $28.6 | -13% |
| 2023 | $28.6 | $33.3 | +16% |
| 2024 | $33.3 | $47.5 | +43% |
| 2025 | $47.5 | $48.6 | +2.3% |
| 2026 YTD | $48.6 | $55.6 | +15% |
EQH has the edge over BAC on returns for 2026, with the stronger performance.